Citation Impact
Citing Papers
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
2012 StandoutScience
[125]I-Spectramide: A novel benzamide displaying potent and selective effects at the D2 dopamine receptor
1989
International Union of Pharmacology nomenclature of adrenoceptors.
1994 StandoutNobel
Adrenergic α2C-Receptors Modulate the Acoustic Startle Reflex, Prepulse Inhibition, and Aggression in Mice
1998 StandoutNobel
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
The neural basis of drug craving: An incentive-sensitization theory of addiction
1993 Standout
The 5-Hydroxytryptamine(1A) Receptor Is Stably Palmitoylated, and Acylation Is Critical for Communication of Receptor with Gi Protein
2004
Differences in the Ligand Binding Properties of the Short and Long Versions of the D2 Dopamine Receptor
1993
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
2004
Neurophysiology and neuropharmacology of hypothalamic magnocellular neurons secreting vasopressin and oxytocin
1991
The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide
1988 StandoutNobel
Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice
2007 StandoutNobel
Regulation of Serotonin1A, Glucocorticoid, and Mineralocorticoid Receptor in Rat and Human Hippocampus: Implications for the Neurobiology of Depression
1998
The use of the patch clamp technique to study second messenger-mediated cellular events
1988 StandoutNobel
Selective adenosine A2A receptor/dopamine D2 receptor interactions in animal models of schizophrenia
1996
Agonist-independent Activation of Gz by the 5-Hydroxytryptamine1A Receptor Co-expressed in Spodoptera frugiperda Cells
1997
Expression of the Human 5-Hydroxytryptamine1A Receptor in Sf9 Cells
1995
Immunocytochemical localization of serotonin1A receptors in the rat central nervous system
1996
Historical review: A brief history and personal retrospective of seven-transmembrane receptors
2004 StandoutNobel
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Antiparkinsonian dopamine agonists: a review of the pharmacokinetics and neuropharmacology in animals and humans
1991
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Synthesis and Release of Dopamine in Rat Brain: Comparison Between Substantia Nigra Pars Compacta, Pars Reticulata, and Striatum
1989 StandoutNobel
Stress and the brain: from adaptation to disease
2005 Standout
Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats
2007
GPCR–Gα fusion proteins: molecular analysis of receptor–G-protein coupling
1999 StandoutNobel
Drugs acting on brain dopamine receptors: A conceptual re-evaluation five years after the first selective D-1 antagonist
1989
Dopamine receptors and the dopamine hypothesis of schizophrenia
1987
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
The superfamily of heptahelical receptors
2000 StandoutNobel
Neurotoxic in vivo models of Parkinson’s disease
2010
Non-motor features of Parkinson disease
2017 Standout
Assessing the Validity of an Animal Model of Deficient Sensorimotor Gating in Schizophrenic Patients
1994
The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptor
1988 StandoutNatureNobel
Quantitative autoradiography of the serotonin transporter to assess the distribution of serotonergic projections from the dorsal raphe nucleus
1994
Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist
1995
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
Seven-transmembrane receptors
2002 StandoutNobel
Chronic pharmacological manipulation of dopamine receptors in brain
1987
Physiological pathways regulating the activity of magnocellular neurosecretory cells
1999
Mechanism of gastroprokinetic effect of EM523, an erythromycin derivative, in dogs
1993 StandoutNobel
5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminals
1993
Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine
1991 StandoutNature
Receptor localization in the mammalian dorsal horn and primary afferent neurons
1997
Cognitive dysfunction and depression in Parkinson’s disease: what can be learned from rodent models?
2012
Involvement of cholecystokinin receptor types in pathways controlling oxytocin secretion
1993
Uropathic Observations in Mice Expressing a Constitutively Active Point Mutation in the 5-HT3AReceptor Subunit
2004 StandoutNobel
Characterization of [3H]Quipazine Binding to 5‐Hydroxytryptamine3 Receptors in Rat Brain Membranes
1989
Molecular Characterization of a Functional cDNA Encoding the Serotonin 1c Receptor
1988 StandoutScienceNobel
A G Protein Couples Serotonin and GABA B Receptors to the Same Channels in Hippocampus
1986 Science
5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus
1986
Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons
1987
Dopamine receptor subtype imbalance in schizophrenia
1987
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Ras-Dependent Activation of Fibroblast Mitogen-Activated Protein Kinase by 5-HT1A Receptor via a G Protein βγ-Subunit-Initiated Pathway
1996 StandoutNobel
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
1990 StandoutScience
Primary Structure And Functional Expression of the 5HT 3 Receptor, A Serotonin-gated Ion Channel
1991 StandoutScienceNobel
Functional role of intrahypothalamic release of oxytocin and vasopressin: consequences and controversies
1995
5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system.
1989 StandoutNobel
The 5-HT3Subtype of Serotonin Receptor Contributes to Nociceptive Processing via a Novel Subset of Myelinated and Unmyelinated Nociceptors
2002 StandoutNobel
[3H]SCH 23390 identifies D-1 binding sites in rat striatum and other brain areas
1986
Ectopic Expression of the Serotonin 1c Receptor and the Triggering of Malignant Transformation
1989 StandoutScienceNobel
5-Hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterization
1988
Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron)
1989
Nervous system distribution of the serotonin 5-HT3 receptor mRNA.
1993 StandoutNobel
Receptor-Binding Profiles of Neuroleptics
1985
Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat
1985
The D-1 Dopamine Receptor and the Search for its Functional Role: From Neurochemistry to Behaviour
1987
Expression of a rat neurotensin receptor in Escherichia coli
1993 StandoutNobel
Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding
1992
Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary.
1981
The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors.
1990 StandoutNobel
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Dopamine in schizophrenia: a review and reconceptualization
1991 Standout
Brain Corticosteroid Receptor Balance in Health and Disease*
1998 Standout
Behavioral Evidence of Depolarization Block of Dopamine Neurons after Chronic Treatment with Haloperidol and Clozapine
2000
Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro.
1987
In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: Implications for drug mechanisms of action
1986
Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(di)-n-propylamino) tetralin ([3H]-8-OH-DPAT)
1986
Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein alpha-subunits.
1992
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
Regional distribution of sultopride and sulpiride in rat brain measured by radioimmunoassay
1983
A point mutation in the seventh hydrophobic domain of the alpha 2 adrenergic receptor increases its affinity for a family of beta receptor antagonists
1991 StandoutNobel
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout
Serotonin receptor knockouts: A moody subject
1998 StandoutNobel
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
1996 StandoutScience
Trafficking of G Protein–Coupled Receptors
2006 StandoutNobel
Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of cortico-striatopallido-thalamic function
1987
The Human 5-HT1A Receptor Expressed in HeLa Cells Stimulates Sodium-dependent Phosphate Uptake via Protein Kinase C
1989 StandoutNobel
Photoaffinity Labelling and Solubilization of the Central 5-HT1AReceptor Binding Site
1987
Dopamine Receptors: From Structure to Function
1998 Standout
Adrenergic receptors. Models for regulation of signal transduction processes.
1990 StandoutNobel
Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues
1989
Differential Alteration of Striatal D-1 and D-2 Receptors Induced by the Long-Term Administration of Haloperidol, Sulpiride or Clozapine to Rats
1985
Works of M.D. Hall being referenced
Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP into the nigrostriatae dopamine pathway—I. Behavioural, neurochemical and histological characterization of the lesion
1988
Modulation of hypothalamic cholecystokinin receptor density with changes in magnocellular activity: A quantitative autoradiographic study
1989
Differential anatomical location of [3H]‐N,n‐propylnorapomorphine and [3 H]‐spiperone binding sites in the striatum and substantia nigra of the rat
1983
Differentiation of pre- and postsynaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents
1986
Dopamine receptor binding sites in the rat superior colliculus
1984
Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs
1985
In situ molecular sizes of the various types of 5-HT binding sites in the rat brain
1986
Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat
1984
Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors
1983
Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats
1984
Differential localization of tachykinin receptors in rat spinal cord
1984
Cation regulation differentiates specific binding of [3 H]sulpiride and [3 H]spiperone to rat striatal preparations
1980
[3H]8‐Hydroxy‐2‐(Di‐n‐Propylamino)Tetralin Binding to Pre‐ and Postsynaptic 5‐Hydroxytryptamine Sites in Various Regions of the Rat Brain
1985